STOCK TITAN

Stratasys and Siemens Healthineers Bring a New Era for Medical Imaging Research With Patient-Specific 3D-Printed Phantoms

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags

Stratasys (NASDAQ: SSYS) and Siemens Healthineers have unveiled groundbreaking research demonstrating the exceptional accuracy of 3D-printed medical imaging phantoms that replicate human anatomy. The collaboration integrates Stratasys' RadioMatrix™ materials and Digital Anatomy® technology with Siemens Healthineers' advanced algorithms.

The joint initiative creates patient-specific anatomical models that accurately replicate anatomy and pathologies, offering a scalable and cost-effective alternative to traditional phantoms and cadavers. The research showed remarkable precision with variances as low as single Hounsfield units (HU) in critical areas like grey matter and veins.

These advanced phantoms enable:

  • Enhanced CT scanner calibration and performance
  • Improved development of imaging algorithms
  • Better training and education in radiology
  • More accurate pre-surgery planning

Stratasys (NASDAQ: SSYS) e Siemens Healthineers hanno presentato una ricerca innovativa che dimostra l'eccezionale precisione dei fantocci medici stampati in 3D che replicano l'anatomia umana. La collaborazione integra i materiali RadioMatrix™ di Stratasys e la tecnologia Digital Anatomy® con gli algoritmi avanzati di Siemens Healthineers.

Questa iniziativa congiunta crea modelli anatomici specifici per il paziente che replicano con precisione l'anatomia e le patologie, offrendo un'alternativa scalabile ed economica ai fantocci tradizionali e ai cadaveri. La ricerca ha mostrato una precisione notevole con variazioni così basse come singole unità di Hounsfield (HU) in aree critiche come la sostanza grigia e le vene.

Questi avanzati fantocci consentono:

  • Una calibrazione e prestazioni migliorate degli scanner CT
  • Un miglioramento nello sviluppo di algoritmi di imaging
  • Una formazione e un'educazione migliori in radiologia
  • Pianificazione pre-operatoria più accurata

Stratasys (NASDAQ: SSYS) y Siemens Healthineers han presentado una investigación innovadora que demuestra la excepcional precisión de los fantomas médicos impresos en 3D que replican la anatomía humana. La colaboración integra los materiales RadioMatrix™ de Stratasys y la tecnología Digital Anatomy® con los algoritmos avanzados de Siemens Healthineers.

Esta iniciativa conjunta crea modelos anatómicos específicos para el paciente que replican con precisión la anatomía y las patologías, ofreciendo una alternativa escalable y rentable a los fantomas tradicionales y a los cadáveres. La investigación mostró una precisión notable con variaciones tan bajas como unidades de Hounsfield (HU) en áreas críticas como la materia gris y las venas.

Estos fantomas avanzados permiten:

  • Mejor calibración y rendimiento de los escáneres CT
  • Mejora en el desarrollo de algoritmos de imagen
  • Mejor formación y educación en radiología
  • Planificación preoperatoria más precisa

Stratasys (NASDAQ: SSYS)Siemens Healthineers가 인간 해부학을 복제한 3D 프린트 의료 이미징 팬텀의 뛰어난 정확성을 입증하는 획기적인 연구를 발표했습니다. 이 협력은 Stratasys의 RadioMatrix™ 재료와 Digital Anatomy® 기술을 Siemens Healthineers의 고급 알고리즘과 통합합니다.

이 공동 이니셔티브는 환자별 해부학 모델을 생성하여 해부학과 병리를 정확하게 복제하며, 전통적인 팬텀 및 시체에 대한 확장 가능하고 비용 효율적인 대안을 제공합니다. 연구 결과는 회색 물질 및 정맥과 같은 중요한 영역에서 단일 Hounsfield 단위(HU)만큼 낮은 변동성을 보이며 놀라운 정밀성을 보여주었습니다.

이러한 고급 팬텀은 다음을 가능하게 합니다:

  • CT 스캐너의 보정 및 성능 향상
  • 이미징 알고리즘 개발 개선
  • 방사선학 교육 및 훈련 개선
  • 수술 전 계획의 정확성 향상

Stratasys (NASDAQ: SSYS) et Siemens Healthineers ont dévoilé des recherches révolutionnaires démontrant l'exceptionnelle précision des fantômes médicaux imprimés en 3D qui reproduisent l'anatomie humaine. La collaboration intègre les matériaux RadioMatrix™ de Stratasys et la technologie Digital Anatomy® avec les algorithmes avancés de Siemens Healthineers.

Cette initiative conjointe crée des modèles anatomiques spécifiques au patient qui reproduisent avec précision l'anatomie et les pathologies, offrant une alternative évolutive et rentable aux fantômes traditionnels et aux cadavres. La recherche a montré une précision remarquable avec des variations aussi faibles que des unités de Hounsfield (HU) dans des domaines critiques tels que la matière grise et les veines.

Ces fantômes avancés permettent:

  • Une calibration et des performances améliorées des scanners CT
  • Un développement amélioré des algorithmes d'imagerie
  • Une meilleure formation et éducation en radiologie
  • Une planification préopératoire plus précise

Stratasys (NASDAQ: SSYS) und Siemens Healthineers haben bahnbrechende Forschungsergebnisse vorgestellt, die die außergewöhnliche Genauigkeit von 3D-gedruckten medizinischen Imaging-Phantomen demonstrieren, die die menschliche Anatomie nachbilden. Die Zusammenarbeit integriert die RadioMatrix™-Materialien von Stratasys und die Digital Anatomy®-Technologie mit den fortschrittlichen Algorithmen von Siemens Healthineers.

Die gemeinsame Initiative schafft patientenspezifische anatomische Modelle, die Anatomie und Pathologien genau nachbilden und eine skalierbare und kosteneffiziente Alternative zu traditionellen Phantomen und Leichnamen bieten. Die Forschung zeigte eine bemerkenswerte Präzision mit Abweichungen von nur wenigen Hounsfield-Einheiten (HU) in kritischen Bereichen wie grauer Substanz und Venen.

Diese fortschrittlichen Phantome ermöglichen:

  • Verbesserte Kalibrierung und Leistung von CT-Scannern
  • Verbesserte Entwicklung von Imaging-Algorithmen
  • Bessere Ausbildung und Schulung in der Radiologie
  • Genauere Planung vor der Operation

Positive
  • Partnership with major healthcare company Siemens Healthineers
  • Breakthrough technology achieving unprecedented accuracy levels
  • Cost-effective solution for medical imaging market
  • Potential for recurring revenue from hospitals and imaging centers
Negative
  • None.

Insights

Stratasys's new collaboration with Siemens Healthineers represents a potentially significant advancement in the company's healthcare vertical, though investors should carefully evaluate both the immediate and long-term revenue implications.

This partnership positions Stratasys at the intersection of two high-growth markets: medical imaging (projected to reach $51.9 billion by 2029) and medical 3D printing (expected to grow at a CAGR of 18.2% through 2030). The development of patient-specific 3D-printed phantoms addresses a critical need in radiology for consistent, reliable imaging models that accurately replicate human tissue characteristics.

What makes this particularly valuable is the unprecedented accuracy achieved—variances as low as single Hounsfield units in critical anatomical structures. This precision enables three revenue-generating applications:

  • CT scanner calibration and performance enhancement for hospitals and imaging centers
  • Algorithm development and AI training datasets for medical imaging companies
  • Education and training programs that reduce reliance on cadavers

From a competitive standpoint, Stratasys's Digital Anatomy technology provides a differentiated offering in the medical 3D printing space. While competitors like 3D Systems also target healthcare applications, Stratasys's RadioMatrix materials specifically engineered to replicate radiopacity characteristics create a technical moat that's now validated by a tier-one medical imaging leader.

However, investors should temper expectations regarding near-term financial impact. Medical technology adoption cycles are notoriously long, typically 2-3 years for new imaging technologies. Additionally, the phantom market represents a relatively small subset of the overall medical imaging ecosystem.

For context, Stratasys generated approximately $629 million in revenue in 2023, with healthcare applications representing a growing but still minority portion. While this partnership enhances their healthcare credentials, it's unlikely to materially impact financials in the next 12-18 months.

The longer-term strategic value may be more significant. As healthcare continues shifting toward personalized medicine, technologies enabling patient-specific solutions should see accelerating demand. Stratasys's positioning at this intersection could eventually translate into a more substantial revenue stream, particularly if they can leverage this technology into adjacent healthcare applications.

Anatomically accurate 3D-printed phantoms replace cadavers, transforming CT imaging and AI algorithm training

EDEN PRAIRIE, Minn. & REHOVOT, Israel & ERLANGEN, Germany--(BUSINESS WIRE)-- Stratasys Ltd. (NASDAQ: SSYS) and Siemens Healthineers recently presented the results of a joint research effort that demonstrates the unprecedented accuracy of the solutions offered by Stratasys to enable 3D-printed medical imaging phantoms to replicate human anatomy.

Stratasys and Siemens Healthineers Bring a New Era for Medical Imaging Research With Patient-Specific 3D-Printed Phantoms (Photo: Business Wire)

Stratasys and Siemens Healthineers Bring a New Era for Medical Imaging Research With Patient-Specific 3D-Printed Phantoms (Photo: Business Wire)

This collaborative effort uses Stratasys’ RadioMatrix™ materials and Digital Anatomy® technology with Siemens Healthineers’ advanced algorithms to significantly improve the quality of complex anatomy medical imaging phantoms, allowing surgeons, researchers, and educators to replace simplistic anatomical phantom models for pre-surgery planning and education.

This new research demonstrates how anatomically accurate, patient-specific 3D-printed phantoms are scalable, cost effective and efficient in developing new CT scan algorithms and improving diagnostic precision. By using 3D-printed anatomic models for radiology, it is possible to offer a patient-specific, anatomical model that accurately replicates anatomy and pathologies.

"The integration of 3D-printing solutions to create patient-realistic CT phantoms, combined with the Digital Anatomy® technology from Stratasys, represents a significant innovation in the field of computed tomography,” said Jesús Fernández Léon, Head of Computed Tomography Product & Clinical Marketing at Siemens Healthineers. “This cooperation not only enhances our ability to assess and verify the performance of modern CT systems but also ensures that our algorithms can rely on a highly realistic depiction of human anatomy. By working together, we are setting new standards in medical imaging.”

The results of the study were shared during this winter’s Radiological Society of North America (RSNA) annual meeting.

The joint efforts will drive innovation in medical imaging through multiple ways:

  • Integrating Stratasys’ advanced Digital Anatomy technology and materials with Siemens Healthineers’ imaging creates patient-specific phantoms with realistic radiopacity and anatomical precision. These models replicate clinical imaging outcomes more closely than existing traditional phantoms, addressing the radiology field’s long-standing need for consistency and reliability while preserving the anatomy and details of potential pathologies and/or variations of anatomy.
  • With the ability to produce repeatable data sets on the same anatomy, these phantoms eliminate ethical, and variability challenges associated with human scans and/or the usage of cadavers.
  • Advanced post-processing including validation data for AI-based software solutions. The ultra-realistic phantoms accelerate the development of imaging algorithms, driving materials innovation, and enabling the exploration of new clinical and academic applications.

By utilization of these kind of 3D-printed phantoms, hospitals and imaging centers can enhance the calibration and performance of CT scanners, ensuring more accurate diagnostics and better patient outcomes. These phantoms are also opening new doors for education, training, and research in radiology, ultimately improving patient outcomes and costs.

“The collaboration between Stratasys and Siemens Healthineers will pave the way for innovations that enhance imaging precision, improve training efficiency, and reduce reliance on cadavers,” said Erez Ben Zvi, Vice President of Healthcare, Stratasys. “This is a game-changer for the medical community. We believe this work can speed up the advancement of medicine and improve patient outcomes.”

The RSNA presentation also highlighted the significant deviations between real and printed models, with variances as low as single Hounsfield units (HU) in critical areas like grey matter and veins. This extraordinary level of accuracy redefines the standards for CT imaging research.

About Stratasys

Stratasys is leading the global shift to additive manufacturing with innovative 3D printing solutions for industries such as aerospace, automotive, consumer products, and healthcare. Through smart and connected 3D printers, polymer materials, a software ecosystem, and parts on demand, Stratasys solutions deliver competitive advantages at every stage in the product value chain. The world’s leading organizations turn to Stratasys to transform product design, bring agility to manufacturing and supply chains, and improve patient care.

To learn more about Stratasys, visit www.stratasys.com, the Stratasys blog, X/Twitter, LinkedIn, or Facebook. Stratasys reserves the right to utilize any of the foregoing social media platforms, including Stratasys’ websites, to share material, non-public information pursuant to the SEC’s Regulation FD. To the extent necessary and mandated by applicable law, Stratasys will also include such information in its public disclosure filings.

Stratasys, Digital Anatomy and RadioMatrix are trademarks or registered trademarks of Stratasys Ltd. and/or its affiliates. All other trademarks are the property of their respective owners.

Media Contacts:

Chris Reese

Stratasys

+1 651-357-0877

chris.reese@stratasys.com

Erik Snider

Stratasys

+1 952-906-8296

erik.snider@stratasys.com

Investor Relations:

Yonah Lloyd

Stratasys

+972 74 745 4919

yonah.lloyd@stratasys.com

Source: Stratasys Ltd.

FAQ

What are the key benefits of Stratasys (SSYS) and Siemens Healthineers' 3D-printed phantoms collaboration?

The collaboration enables creation of anatomically accurate, patient-specific phantoms that improve CT imaging precision, enhance scanner calibration, and eliminate the need for cadavers in medical research and training.

How accurate are the 3D-printed phantoms developed by Stratasys (SSYS)?

The phantoms achieve exceptional accuracy with variances as low as single Hounsfield units (HU) in critical areas like grey matter and veins.

What technologies are used in Stratasys (SSYS) medical imaging phantoms?

The phantoms utilize Stratasys' RadioMatrix™ materials and Digital Anatomy® technology combined with Siemens Healthineers' advanced algorithms.

How will Stratasys (SSYS) 3D-printed phantoms impact medical training and research?

The phantoms provide scalable, cost-effective solutions for pre-surgery planning, education, and CT scan algorithm development while offering consistent, repeatable data sets.

Stratasys Ltd

NASDAQ:SSYS

SSYS Rankings

SSYS Latest News

SSYS Stock Data

760.25M
57.58M
19.35%
51.97%
2.18%
Computer Hardware
Technology
Link
United States
Eden Prairie